Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Nondepolarizing neuromuscular blocking agents

Drugs that may interact with capreomycin include aminoglycosides and nondepolarizing neuromuscular blocking agents. [Pg.1731]

Rocuronium bromide and other nondepolarizing neuromuscular blocking agents Ambenonium (i.s.)... [Pg.300]

Barohn RJ, Jackson CE, Rogers SJ, Ridings LW, McVey AL. Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids. Muscle Nerve 1994 17(6) 647-54. [Pg.553]

Albrecht A, Wedel DJ, Gronert GA. Masseter muscle rigidity and nondepolarizing neuromuscular blocking agents. Mayo Chn Proc 1997 72(4) 329-32. [Pg.3269]

A course of ECT generally consists of 6 to 12 treatments administered either unilaterally or bilaterally two to three times weekly. A rapid therapeutic response (10 to 14 days) has been reported. Although there are no absolute contraindications to the use of ECT, several conditions are associated with increased risk. These include increased intracranial pressure, cerebral lesions, recent myocardial infarction, recent intracerebral hemorrhage, bleeding, or otherwise unstable vascular condition. The use of an anesthetic as well as a nondepolarizing neuromuscular blocking agent decreases the morbidity associated with ECT. ... [Pg.1239]

Cisatracurium is a nondepolarizing neuromuscular blocking agent that binds competitively to cholinergic receptors on the motor end-plate to antagonize action of acetylcholine. [Pg.159]

Gallamine, a nondepolarizing neuromuscular blocking agent (1 mg/kg IV), is used as an adjunct to anesthesia to induce skeletal muscle relaxation, facilitate intubation and mechanical ventilation, reduce fractures and dislocations, and to weaken muscle contractions in pharmacologically or electrically induced convulsions (see also Figure 99). [Pg.290]

Nondepolarizing neuromuscular blocking agent protot3pe competitive nicotinic blocker. Releases histamine and may cause hypotension. Analogs pancuronium, atracurium, vecuronium, and other -curiums and -curoniums. Antidote cholinesterase inhibitor, eg, neostigmine. [Pg.562]

C. Neostigmine is used primarily to reverse the effect of nondepolarizing neuromuscular blocking agents. [Pg.490]

B. They may inhibit or reverse the actions of nondepolarizing neuromuscular blocking agents (eg, pancuronium, vecuronium, etc). Neostigmine Is used therapeutically for this purpose. [Pg.490]

Swen J, Rashkovsky OM, Ket JM, Koot HWJ, Hermans J, Agostmi S. Interaction between nondepolarizing neuromuscular blocking agents and inhalational anesthetics. Anesfh Analg (1989) 69, 752-5. [Pg.102]

Larsson L, Li X, Edstrom L, et al. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids mechanisms at the cellular and molecular levels. Crit Care Med 2000 28(l) 34-45. [Pg.81]


See other pages where Nondepolarizing neuromuscular blocking agents is mentioned: [Pg.195]    [Pg.98]    [Pg.346]    [Pg.186]    [Pg.595]    [Pg.286]    [Pg.416]    [Pg.3611]    [Pg.591]    [Pg.593]    [Pg.1561]    [Pg.186]    [Pg.249]    [Pg.270]    [Pg.574]    [Pg.655]    [Pg.726]    [Pg.550]    [Pg.551]    [Pg.125]   


SEARCH



Blocking agents

Neuromuscular

Neuromuscular block

Neuromuscular blocking agents

© 2024 chempedia.info